Ammonia
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11118 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 26 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | acrodermatitis chronica atrophicans | KG + DL |
| 2 | neonatal dermatomyositis | KG + DL |
| 3 | acne keloid | KG + DL |
| 4 | secondary interstitial lung disease specific to childhood associated with a connective tissue disease | KG + DL |
| 5 | amyopathic dermatomyositis | KG + DL |
| 6 | hydroa vacciniforme, familial | KG + DL |
| 7 | exanthem (disease) | KG + DL |
| 8 | vulvar inverted follicular keratosis | KG + DL |
| 9 | lichen planus, familial | KG + DL |
| 10 | isolated congenital adermatoglyphia | KG + DL |
| 11 | Beare-Stevenson cutis gyrata syndrome | KG + DL |
| 12 | dry eye syndrome | KG + DL |
| 13 | lichen planus pemphigoides | KG + DL |
| 14 | hypertrophic lichen planus | KG + DL |
| 15 | annular atrophic lichen planus | KG + DL |
| 16 | lichen planus pigmentosus | KG + DL |
| 17 | zinc, elevated plasma | KG + DL |
| 18 | alopecia universalis onychodystrophy vitiligo | KG + DL |
| 19 | lichen disease | KG + DL |
| 20 | cholesteatoma (disease) | KG + DL |
| 21 | acquired keratosis | KG + DL |
| 22 | pityriasis lichenoides | KG + DL |
| 23 | severe dermatitis-multiple allergies-metabolic wasting syndrome | KG + DL |
| 24 | hereditary papulotranslucent acrokeratoderma | KG + DL |
| 25 | prolidase deficiency | KG + DL |
| 26 | familial chilblain lupus | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.